MYLAN CF 135 MYLAN CF 135 Pill - blue & yellow capsule-shape
Pill with imprint MYLAN CF 135 MYLAN CF 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Mylan Pharmaceuticals Inc.
Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN CF 135 MYLAN CF 135
Fenofibric Acid Delayed-Release
- Imprint
- MYLAN CF 135 MYLAN CF 135
- Strength
- 135 mg
- Color
- Blue & Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
gelatin,
hydroxypropyl cellulose,
hypromelloses,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polysorbate 80,
povidone,
sodium lauryl sulfate,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferric oxide yellow,
FD&C Blue No. 2,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-2590 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0196 (Discontinued) | UDL Laboratories Inc. |
More about fenofibric acid
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (25)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.